Cite
PCR31 Assessment of Pain, Stiffness, and Physical Functioning Pre and During Burosumab Among Adults with X-Linked Hypophosphatemia: Results from a Multinational, Long-Term, Prospective Outcomes Disease Monitoring Program.
MLA
Yang, E., et al. “PCR31 Assessment of Pain, Stiffness, and Physical Functioning Pre and During Burosumab Among Adults with X-Linked Hypophosphatemia: Results from a Multinational, Long-Term, Prospective Outcomes Disease Monitoring Program.” Value in Health, vol. 26, no. 6, June 2023, p. S317. EBSCOhost, https://doi.org/10.1016/j.jval.2023.03.1811.
APA
Yang, E., Chen, Z., Hetzer, J., Kruger, E., & Skrinar, A. (2023). PCR31 Assessment of Pain, Stiffness, and Physical Functioning Pre and During Burosumab Among Adults with X-Linked Hypophosphatemia: Results from a Multinational, Long-Term, Prospective Outcomes Disease Monitoring Program. Value in Health, 26(6), S317. https://doi.org/10.1016/j.jval.2023.03.1811
Chicago
Yang, E., Z. Chen, J. Hetzer, E. Kruger, and A. Skrinar. 2023. “PCR31 Assessment of Pain, Stiffness, and Physical Functioning Pre and During Burosumab Among Adults with X-Linked Hypophosphatemia: Results from a Multinational, Long-Term, Prospective Outcomes Disease Monitoring Program.” Value in Health 26 (6): S317. doi:10.1016/j.jval.2023.03.1811.